Patents by Inventor Ee Ling Seah

Ee Ling Seah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds for medicinal applications
    Patent number: 11007274
    Abstract: The present invention provides compounds for use in treating and/or preventing influenza. The compound comprises a first and second domain in which the first domain comprises at least one anchoring group which binds to the surface of influenza viruses and the second domain comprises at least one anionic group. The first and second domains are covalently linked. Also provided are pharmaceutically acceptable salts, solvates, prodrugs or stereoisomer of the compounds.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: May 18, 2021
    Assignee: Ausvir Therapeutics Pty LTD
    Inventors: Betty Jin, Ee-Ling Seah, Paul Arthur Jones, Peter James Jenkins, Henry Kenneth Windle, Wen Yang Wu
  • Medicinal carbohydrates for treatment of respiratory conditions
    Patent number: 10195226
    Abstract: A method of promoting recovery of cell viability of a damaged respiratory cell. The method includes a step of administering to the cell at least one pharmaceutically acceptable compound, which accelerates sialyglycoconjugate biosynthesis to restore sialylglycoconjugates on the surface of the respiratory cell. Also disclosed are a method and a pharmaceutical composition, both for treating a respiratory condition.
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: February 5, 2019
    Assignee: Australian Biomedical Company Pty Ltd.
    Inventors: Betty Jin, Paul Arthur Jones, Ee Ling Seah, Wen Yang Wu, Peter James Jenkins
  • COMPOUNDS FOR MEDICINAL APPLICATIONS
    Publication number: 20180264128
    Abstract: The present invention provides compounds for use in treating and/or preventing influenza. The compound comprises a first and second domain in which the first domain comprises at least one anchoring group which binds to the surface of influenza viruses and the second domain comprises at least one anionic group. The first and second domains are covalently linked. Also provided are pharmaceutically acceptable salts, solvates, prodrugs or stereoisomer of the compounds.
    Type: Application
    Filed: May 18, 2018
    Publication date: September 20, 2018
    Applicant: Australian Biomedical Co. Pty Ltd.
    Inventors: Betty Jin, Ee-Ling Seah, Paul Arthur Jones, Peter James Jenkins, Henry Kenneth Windle, Wen Yang Wu
  • MEDICINAL CARBOHYDRATES FOR TREATMENT OF RESPIRATORY CONDITIONS
    Publication number: 20150238512
    Abstract: A method of promoting recovery of cell viability of a damaged respiratory cell. The method includes a step of administering to the cell at least one pharmaceutically acceptable compound, which accelerates sialyglycoconjugate biosynthesis to restore sialylglycoconjugates on the surface of the respiratory cell. Also disclosed are a method and a pharmaceutical composition, both for treating a respiratory condition.
    Type: Application
    Filed: May 8, 2015
    Publication date: August 27, 2015
    Inventors: Betty Jin, Paul Arthur Jones, Ee Ling Seah, Wen Yang Wu, Peter James Jenkins
  • Medicinal carbohydrates for treatment of respiratory conditions
    Patent number: 9040503
    Abstract: A method of promoting recovery of cell viability of a damaged respiratory cell. The method includes a step of administering to the cell at least one pharmaceutically acceptable compound, which accelerates sialyglycoconjugate biosynthesis to restore sialylglycoconjugates on the surface of the respiratory cell. Also disclosed are a method and a pharmaceutical composition, both for treating a respiratory condition.
    Type: Grant
    Filed: July 2, 2010
    Date of Patent: May 26, 2015
    Assignee: Australian Biomedical Company Pty Ltd.
    Inventors: Betty Jin, Paul Arthur Jones, Ee Ling Seah, Wen Yang Wu, Peter James Jenkins
  • MEDICINAL CARBOHYDRATES FOR TREATMENT OF RESPIRATORY CONDITIONS
    Publication number: 20120142619
    Abstract: The present invention relates to a method and compounds of Formula (1) and/or (2) or their pharmaceutically acceptable inorganic or organic salt thereof, and their compositions for treating respiratory conditions including post viral/bacterial infections, acute/chronic bronchitis, COPD, cystic fibrosis, and inflammatory conditions. It has been found by the applicants that the compounds of Formula (1) and/or (2) or their pharmaceutically acceptable inorganic or organic salt thereof could speed up the recovery of the viability of damaged respiratory tract cells by restoring sialylglyco-conjugates on their surface.
    Type: Application
    Filed: July 2, 2010
    Publication date: June 7, 2012
    Applicant: Australian Blomedical Company Pty Ltd,
    Inventors: Betty Jin, Paul Arthur Jones, Ee Ling Seah, Wen Yang Wu, Peter James Jenkins